###begin article-title 0
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 44 49 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The CD85j+ NK Cell Subset Potently Controls HIV-1 Replication in Autologous Dendritic Cells
###end article-title 0
###begin p 1
Conceived and designed the experiments: FB DS GP. Performed the experiments: DS VA CD TK GP. Analyzed the data: DS VA CD GP. Wrote the paper: FB DS VA GP.
###end p 1
###begin p 2
Current address: Sanofi-Aventis, Chilly-Mazarin, Paris, France
###end p 2
###begin p 3
###xml 284 292 284 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 596 597 596 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 716 717 716 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 822 823 822 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1363 1364 1363 1364 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 109 112 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 247 250 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 355 360 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 550 555 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 631 636 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 682 687 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 769 774 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 788 793 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 930 935 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1252 1257 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1387 1392 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1542 1547 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Natural killer (NK) cells and dendritic cells (DC) are thought to play critical roles in the first phases of HIV infection. In this study, we examined changes in the NK cell repertoire and functions occurring in response to early interaction with HIV-infected DC, using an autologous in vitro NK/DC coculture system. We show that NK cell interaction with HIV-1-infected autologous monocyte-derived DC (MDDC) modulates NK receptor expression. In particular, expression of the CD85j receptor on NK cells was strongly down-regulated upon coculture with HIV-1-infected MDDC. We demonstrate that CD85j+ NK cells exert potent control of HIV-1 replication in single-round and productively HIV-1-infected MDDC, whereas CD85j- NK cells induce a modest and transient decrease of HIV-1 replication. HIV-1 suppression in MDCC by CD85j+ NK cells required cell-to-cell contact and did not appear mediated by cytotoxicity or by soluble factors. HIV-1 inhibition was abolished when NK-MDDC interaction through the CD85j receptor was blocked with a recombinant CD85j molecule, whereas inhibition was only slightly counteracted by blocking HLA class I molecules, which are known CD85j ligands. After masking HLA class I molecules with specific antibodies, a fraction of HIV-1 infected MDDC was still strongly stained by a recombinant CD85j protein. These results suggest that CD85j+ NK cell inhibition of HIV-1 replication in MDDC is mainly mediated by CD85j interaction with an unknown ligand (distinct from HLA class I molecules) preferentially expressed on HIV-1-infected MDDC.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 159 162 159 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Bottino1">[1]</xref>
###xml 163 166 163 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Moretta1">[3]</xref>
###xml 359 362 359 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Bottino1">[1]</xref>
###xml 364 367 364 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Boyton1">[4]</xref>
###xml 573 576 573 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Bottino1">[1]</xref>
###xml 898 901 898 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Moretta1">[3]</xref>
###xml 903 906 903 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Moretta2">[5]</xref>
###xml 1198 1201 1198 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Moretta2">[5]</xref>
###xml 1203 1206 1203 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Marcenaro1">[6]</xref>
###xml 1428 1431 1428 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Moretta1">[3]</xref>
Natural killer (NK) cells are a key component of innate immune responses to pathogens and tumour cells, through cytokine secretion and lysis of abnormal cells [1]-[3]. NK function is regulated by a balance between activating and inhibitory signals that are generated by an array of NK cell surface receptors (NKR) upon engagement by specific cellular ligands [1], [4]. NK inhibitory receptors specific for MHC class I molecules, by delivering inhibitory signals to NK cells, can prevent unwanted responses to normal cells, that express a complete set of self MHC molecules [1]. Thus, NK cell interaction with normal autologous cells leads to NK cell inactivation. However, dendritic cells (DC) are an exception to this rule, as they are targeted by NK cells despite normal MHC class I expression. It has recently been shown that the cognate interaction between NK cells and DC results in crosstalk [3], [5] thought to be crucial for optimal induction of both innate and adaptive responses. DC can prime and induce proliferation of NK cells, which, once activated, acquire the ability to kill immature DC (iDC), through engagement of the activating receptor NKp30, and may also induce DC maturation [5], [6]. DC infected by pathogens upregulate HLA class I, become resistant to NK-mediated lysis, and express CCR7, thus acquiring the ability to migrate to secondary lymphoid organs where the adaptive immune response takes place [3].
###end p 5
###begin p 6
###xml 69 72 69 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Alter1">[7]</xref>
###xml 73 77 73 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Tasca1">[11]</xref>
###xml 237 238 237 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</sup>
###xml 242 247 242 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(dim)</sup>
###xml 284 285 284 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</sup>
###xml 289 297 289 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(bright)</sup>
###xml 301 302 301 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 312 316 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Alter2">[12]</xref>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Alter3">[13]</xref>
###xml 412 416 412 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Mavilio2">[14]</xref>
###xml 572 576 572 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Kottilil1">[15]</xref>
###xml 665 669 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Kottilil2">[16]</xref>
###xml 770 774 770 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Mavilio3">[17]</xref>
###xml 913 917 913 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Tasca1">[11]</xref>
###xml 968 969 968 969 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</sup>
###xml 973 974 973 974 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1196 1199 1196 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Mavilio1">[9]</xref>
###xml 53 58 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 173 178 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 353 361 <span type="species:ncbi:9606">patients</span>
###xml 517 525 <span type="species:ncbi:9606">patients</span>
###xml 642 647 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 656 664 <span type="species:ncbi:9606">patients</span>
###xml 761 769 <span type="species:ncbi:9606">patients</span>
###xml 818 823 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 833 841 <span type="species:ncbi:9606">patients</span>
###xml 1034 1039 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Both NK cells and NK-DC interactions are affected by HIV-1 infection [7]-[11]. A deregulation of NK cell subset distribution and function was already described during acute HIV-1 infection, with elevated NK cell numbers, expansion of CD3-CD56(dim) NK cells, and early depletion of CD3-CD56(bright)CD16- NK cells [12], [13]. In chronic infection viremic patients showed an accumulation of CD3-CD56-CD16+ NK cells [14]. NK cell activity correlates negatively with the level of viral replication and declines rapidly in patients starting highly active antiretroviral therapy [15]. Both NK cell cytoxicity and cytokine production are impaired in HIV-1 viremic patients [16]. Accordingly, the expression of activating and/or inhibitory receptors is altered in these patients [17]. It has also been shown that NK cells from HIV-1-infected patients are defective in their capacity to lyse autologous monocyte-derived iDC[11]. In addition, in vitro interactions between a CD56-CD16+ subset of natural killer (NK) cells and autologous DC from HIV-1-infected viremic individuals (but not aviremic individuals) are markedly impaired and likely interfere with the development of an effective immune response [9]
###end p 6
###begin p 7
###xml 242 246 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Kottilil1">[15]</xref>
###xml 248 252 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Fauci1">[18]</xref>
###xml 392 396 392 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Martin1">[19]</xref>
###xml 418 419 418 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 508 509 508 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 518 522 518 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Alter4">[20]</xref>
###xml 529 536 529 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 749 753 749 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-ScottAlgara2">[21]</xref>
###xml 755 759 755 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Ravet1">[22]</xref>
###xml 76 81 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 441 446 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 482 487 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 673 678 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 831 834 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
However, there is also evidence suggesting a protective role of NK cells in HIV-1 infection Preserved NK cell activity and number correlate with lower plasma viral load and slower progression to the acquired immune deficiency syndrome (AIDS) [15], [18]. The combined expression of the activating KIR3DS1 receptor and the HLA-B Bw4-80I allele has been associated to slower disease progression [19]. Furthermore, KIR3DS1+ NK cells can inhibit HIV-1 replication in vitro in autologous HIV-1-infected Bw4-80I CD4+ T cells [20]. High ex vivo NK cell cytotoxic activity and cytokine production, in association with the expansion of particular NK cell subsets, have been found in HIV-1-exposed but uninfected (EU) Vietnamese intravascular drug users (IDU) [21], [22]. Altogether, these data point to a protective role of NK cells against HIV infection and disease.
###end p 7
###begin p 8
###xml 58 62 58 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Alter2">[12]</xref>
###xml 446 450 446 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Donaghy1">[23]</xref>
###xml 44 47 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 334 339 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 376 381 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 662 667 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
NK cell responses are induced very early in HIV infection [12]. The innate immune response against the virus is likely crucial both for the subsequent course of the infection and for the induction of an efficient adaptive response. NK cells encounter DC in sites of infection or inflammation, and their interaction may be modified by HIV-1 infection. Indeed, iDC infection by HIV-1 alters their maturation and their capacity to secrete cytokines [23]. These alterations may, in turn, affect their interaction with NK cells, modulating both NK cell receptor expression and function. Conversely, activated NK cells may exert antiviral activity and protect DC from HIV-1 infection.
###end p 8
###begin p 9
###xml 169 177 169 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 84 89 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 210 213 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
To study the impact on NK cell receptor repertoire and functions of DC infection by HIV-1, and to address the role of NK cells in controlling DC infection, we set up an in vitro model of NK cell coculture with HIV-infected autologous monocyte-derived DC (MDDC). We found changes in the expression of several NK cell receptors and, remarkably, a potent capacity of a particular NK cell subset, expressing the CD85j receptor, to suppress viral replication in infected MDDC.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
###xml 25 30 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
NK cell interaction with HIV-1-infected MDDC modifies NK cell repertoire expression
###end title 11
###begin p 12
###xml 463 469 463 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g001">Fig 1a</xref>
###xml 507 513 507 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g001">Fig 1a</xref>
###xml 627 635 627 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g001">Fig 1a,b</xref>
###xml 843 852 843 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g001">Fig. 1a,b</xref>
###xml 1085 1091 1085 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g001">Fig 1b</xref>
###xml 1190 1196 1190 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g001">Fig 1b</xref>
###xml 281 284 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 486 491 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 591 596 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 713 718 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1066 1069 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
After coculture with autologous uninfected MDDC we observed NK cell proliferation and up-regulation of all the NK cell receptors analyzed, in agreement with previous reports (data not shown). We then investigated NK cell proliferation and receptor expression after co-culture with HIV-infected MDDC. The percentages of proliferating NK cells, indicated by a decrease in CFSE fluorescence, were not significantly different between cocultures with uninfected MDDC (Fig 1a top panels) and HIV-1-infected MDDC (Fig 1a bottom panels). In contrast, some NK receptors were differently modulated by HIV-1-infected and uninfected MDDC (Fig 1a,b). For example, the expression of CD85j and CD161 on NK cells cocultured with HIV-1-infected MDDC was decreased and increased, respectively, compared to their expression after coculture with uninfected MDDC (Fig. 1a,b), whereas NKp30 was upregulated to similar levels in both conditions. Despite variations among the donors, a strong decrease in CD85j receptor expression on NK cells was consistently observed after coculture with HIV-infected MDDC (Fig 1b). We also observed a significant increase in CD161 expression and a decrease in CD244 expression (Fig 1b).
###end p 12
###begin title 13
###xml 60 65 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Changes in NK cell receptor expression after coculture with HIV-1-infected MDDC.
###end title 13
###begin p 14
###xml 134 135 134 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 138 139 138 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 220 225 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 353 358 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 553 558 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 739 742 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(a) Dual-label flow cytometric analysis of NK cell proliferation (decrease in CFSE fluorescence) and NKR expression gated on CD16/CD56+CD3- cells. NK cells were stained after 5 days of coculture with uninfected (top) or HIV-1-infected (bottom) MDDC. A representative experiment showing the expression of three NK cell receptors differently modulated by HIV-1-infected MDDC, CD85j (down-regulated), CD161 (up-regulated) and NKp30 (not significantly changed). (b) Overall modifications in the percentage of NKR expression on NK cells after coculture with HIV-1-infected MDDC. Results are expressed as the percentage decrease (negative values) or increase (positive values) in NK cells expressing the different receptors after coculture with HIV-infected MDDC in comparison to coculture with uninfected MDDC. Means+SE of 9 independent experiments. * p<0.05, **p<0.01
###end p 14
###begin title 15
###xml 5 6 5 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
CD85j+ NK cells inhibit HIV-1 replication in infected MDDC
###end title 15
###begin p 16
###xml 161 162 161 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 241 242 241 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 268 269 268 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 333 334 333 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 344 345 344 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 404 411 404 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g002">Fig. 2a</xref>
###xml 443 446 443 446 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bal</sub>
###xml 489 490 489 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 503 504 503 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 700 701 700 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 746 753 746 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g002">Fig. 2b</xref>
###xml 837 838 837 838 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 967 968 967 968 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 978 979 978 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 990 997 990 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g002">Fig. 2b</xref>
###xml 1049 1050 1049 1050 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 101 106 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 181 186 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 438 441 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 874 879 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1015 1020 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
As CD85j was the NK receptor whose expression was by far the most strongly altered in coculture with HIV-1-infected MDDC, we investigated the impact of the CD85j+ NK cell subset on HIV-1 replication in MDDC. We isolated CD85j-enriched (CD85j+) and CD85-depleted (CD85j-) NK cells and analyzed NKR expression on the two subsets. CD85j+ and CD85j- NK cells did not differ in their expression of other NKR (Fig. 2a). MDDC were infected with HIV-1Bal and incubated 2 hours later with the CD85j+ or the CD85j- NK cell subset, in parallel with the total NK cell population. Viral replication, reflected by Gag p24 protein levels in culture supernatants, was strongly decreased in MDDC cocultured with CD85j+ NK cells compared to MDDC without NK cells (Fig. 2b). A modest and transient decrease of p24 was observed in MDDC cocultures with CD85j- NK cells. An intermediate level of HIV-1 inhibition was observed in MDDC cocultured with total NK cells that comprise both CD85j+ and CD85j- NK cells (Fig. 2b). Suppression of HIV-1 replication in MDDC by CD85j+ NK cells was observed in 14 out of 17 donors tested.
###end p 16
###begin title 17
###xml 62 63 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 15 20 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Suppression of HIV-1 replication in infected MDDC by the CD85j+ NK cell subset.
###end title 17
###begin p 18
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 182 185 182 185 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bal</sub>
###xml 270 271 270 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 280 281 280 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 702 703 702 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 712 713 712 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 907 908 905 906 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 964 965 962 963 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 177 180 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 299 304 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 596 601 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(a) NKR expression on purified CD85j+ and CD85j- NN cell subsets. Results are expressed as percentage of receptor expression in the given subset+SE. (b) MDDC were infected with HIV-1Bal and then cultured alone (DC) or incubated with total NK cells (NK) or with the CD85j+ or CD85j- NK cell subsets. HIV-1 replication was measured by p24 production at the indicated time points. Mean+SE of p24 levels in 8 independent experiments using cells from different donors. p24 levels in NK/MDDC cocultures were compared to those in MDDC cultures * p<0.02, **p<0.001. (b) MDDC were one-round infected with HIV-1/BaL pseudotypes and then cultured alone (DC) or incubated with total NK cells (NK) or with the CD85j+ or CD85j- NK cell subsets. Ninety-six hours later, cells were lysed and luciferase activities were measured. Results are expressed as means+/-SE of luciferase activity of 4 independent experiments. CD85j+ NK cells induced higher levels of inhibition than CD85j- NK cells. * p<0.05
###end p 18
###begin p 19
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 376 377 376 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 531 532 531 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 543 549 543 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g002">Fig 2c</xref>
###xml 585 586 585 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 141 146 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 175 180 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 288 293 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 450 455 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 644 649 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To assess whether CD85j+ NK cells can affect viral replication already at the first cycle, we used an envelope-defective luciferase reporter HIV-1 virus complemented with the HIV-1 BaL Env in single-round infections. In this system, luciferase expression reflects the expression of early HIV-1 genes, after completion of the first steps of viral replication. Addition of CD85j+ NK cells to infected MDDC achieved significantly stronger inhibition of HIV-1 replication, as measured by luciferase activity in cell lysates, than CD85j- NK cells (Fig 2c). These results indicate that CD85j+ NK cell-mediated inhibition affects a post-entry step of HIV-1 replication before translation of early viral proteins.
###end p 19
###begin title 20
###xml 35 36 35 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 suppressive capacity of CD85j+ NK cell is induced by infected MDDC despite decreased cytotoxic activity
###end title 20
###begin p 21
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 355 362 355 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g003">Fig. 3a</xref>
###xml 379 398 379 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g003">Fig. 3b, left panel</xref>
###xml 442 443 442 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 472 473 472 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 629 637 629 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g003">Fig 3a,b</xref>
###xml 689 690 689 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 698 699 698 699 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 706 733 706 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g003">Fig 3a, B1 and B2 quadrants</xref>
###xml 876 877 876 877 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1098 1099 1098 1099 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1323 1324 1323 1324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1465 1466 1465 1466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1538 1541 1538 1541 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bal</sub>
###xml 1978 1981 1978 1981 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bal</sub>
###xml 2031 2037 2031 2037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g004">Fig 4a</xref>
###xml 2043 2050 2043 2050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g002">Fig. 2b</xref>
###xml 2062 2063 2062 2063 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2242 2251 2242 2251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g004">Fig. 4a,b</xref>
###xml 2275 2276 2275 2276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2306 2307 2306 2307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2459 2468 2459 2468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g004">Fig. 4a,b</xref>
###xml 2521 2522 2521 2522 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 2644 2653 2644 2653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g004">Fig. 4a,b</xref>
###xml 2724 2725 2724 2725 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2756 2757 2756 2757 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2767 2768 2767 2768 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 2816 2823 2816 2823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g004">Fig. 4c</xref>
###xml 2882 2889 2882 2889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g003">Fig. 3b</xref>
###xml 2958 2959 2958 2959 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 38 43 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 223 228 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 558 563 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 751 754 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 908 913 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 961 966 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1300 1305 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1370 1375 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1533 1536 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1630 1635 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1686 1691 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1895 1900 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1951 1956 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1973 1976 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 2106 2111 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2195 2200 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2405 2410 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2558 2563 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2925 2928 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 2983 2988 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To evaluate whether the inhibition of HIV-1 replication in infected DC by CD85j+ NK cells might be related to NK cytolytic activity, we first analyzed the effect of co-culturing NK cells with DC infected or not infected by HIV-1 on NK cytolytic activity. The three NK cell populations showed similar lytic capacities after coculture with uninfected MDDC (Fig. 3a, top panels and Fig. 3b, left panel). In contrast, total NK cells and the CD85j+ subset, but not by the CD85j- subset, showed a significant reduction in their lytic activity after coculture with HIV-1-infected MDDC in comparison with coculture with uninfected MDDC (Fig 3a,b). Similar trends were observed for the lysis of GFP- and GFP+ MDDC (Fig 3a, B1 and B2 quadrants) suggesting that HIV replication in MDDC does not modify MDDC susceptibility to NK cell lysis. The decrease in the cytolytic capacity of CD85j+ NK cells after coculture with HIV-1-infected MDDC suggested that the inhibition of HIV-1 replication in MDDC by this NK cell subset was not mediated by cytoxicity. However, we could not exclude the possibility that CD85j+ NK cells might have "exhausted" their cytotoxic activity during coculture with infected MDDC and then lost their suppressive activity. To specifically address this point, we examined whether the anti-HIV-1 activity of CD85j+ NK cells was maintained after coculture with HIV-1-infected MDDC, despite the decrease in their cytolytic capacity. Total NK cells and CD85j- NK cells were studied in parallel. After 5 days of coculture with HIV-1Bal-infected MDDC, each subset of NK cells was incubated with MDDC previously infected with HIV-1/GFP and the GFP expression in MDDC was monitored. HIV-1/GFP was used in these experiments despite not expressing the Nef protein that affects the surface expression of HLA class I molecules (ligands for CD85j and other NK cell receptors), since the levels of HIV-1 suppression by CD85j NK cells in DC infected with HIV-1/GFP or with the HIV-1Bal strain that express Nef were equivalent (compare Fig 4a with Fig. 2b). The CD85j+ NK cell subset was still able to suppress HIV-1 replication, inducing levels of inhibition similar to those achieved when added to HIV-1-infected DC immediately after infection (Fig. 4a,b). The percentage of GFP+ MDDC in cocultures with CD85j+ NK cells was significantly reduced throughout the study period in both cases, in comparison with HIV-1/GFP-infected MDDC cultured without of NK cells (Fig. 4a,b). As already observed in previous experiments, CD85j- NK cells only partially controlled HIV-1/GFP replication, while total NK cells induced an intermediate level of control (Fig. 4a,b). Interestingly, only a not stastistically significant decrease of GFP+ MDDC was induced by both CD85j+ and CD85j- NK cells from cocultures with uninfected MDDC (Fig. 4c), despite both subsets maintained cytolytic capacity (see Fig. 3b). These results confirmed that the HIV-suppressive capacity of CD85j+ NK cells is induced by HIV-1-infected MDDC, and that it cannot be explained by their cytolytic capacity.
###end p 21
###begin title 22
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 79 84 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Decrease in CD85j+ NK cell cytotoxic activity against DC after co-culture with HIV-1-infected DC.
###end title 22
###begin p 23
###xml 551 552 551 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 561 562 561 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 933 937 933 937 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> Bal</sub>
###xml 184 189 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 253 258 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 311 314 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 342 345 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 347 351 <span type="species:ncbi:12721">GFP-</span>
###xml 489 494 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 602 605 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 628 633 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 649 652 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 928 933 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(a) Cytolytic activity of total NK cells (NK), CD85j-enriched NK cells (CD85j+) and CD85j-depleted NK cells (CD85j-) derived from 5-day cocultures with uninfected MDDC (top panels) or HIV-1-infected MDDC (bottom panels) were analyzed for their lysis of HIV-1/GFP infected MDDC. Lysis of target MDDC replicating HIV (GFP+) and not replicating HIV (GFP-) are measured by caspase staining (quadrants B1 and B2, respectively). A representative experiment is shown. (b) Percentages of lysis of HIV-1/GFP+ MDDC target cells by total NK cells or by the CD85j+ or CD85j- subset coculture with uninfected MDDC (HIV-, left panel) or with HIV-1-infected MDDC (HIV+, right panel). Results of 4 independent experiments are summarized. Boxes and whisker plots show the percentiles and median distribution of caspase-stained MDDC. Significant differences between NK cells from cocultures with uninfected MDDC and NK cells from cocultures with HIV-1 Bal-infected MDDC are indicated, **p<0.01.
###end p 23
###begin title 24
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 45 50 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 130 135 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Maintenance of CD85j+ NK cell suppression of HIV-1 replication in DC despite the loss of cytotoxic activity after co-culture with HIV-1-infected DC.
###end title 24
###begin p 25
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 149 150 149 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 159 160 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 217 220 217 220 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bal</sub>
###xml 72 77 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 78 82 <span type="species:ncbi:12721">GFP-</span>
###xml 212 215 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 276 281 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 282 286 <span type="species:ncbi:12721">GFP-</span>
###xml 313 318 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 541 546 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 547 551 <span type="species:ncbi:12721">GFP-</span>
(a) NK cells (NK) or the CD85j+ or CD85j- NK cell subsets were added to HIV-1/GFP-infected MDDC 2 hours after infection. (b, c) NK cells or the CD85j+ or CD85j- NK cell subsets derived from 5-day cocultures with HIV-1Bal-infected MDDC (b) or uninfected MDDC (c) were added to HIV-1/GFP-infected MDDC. Kinetics of HIV-1/GFP replication are expressed as percentages of MDDC cells expressing GFP (means+SE) at the indicated time points in eight independent experiments (a) or three independent experiments (b,c) Significant differences between HIV-1/GFP-infected MDDC cultures without NK cells (DC) and MDDC/NK cocultures on day 14 are indicated * p<0.05, **p<0.001.
###end p 25
###begin title 26
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 11 14 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Control of HIV replication in DC by CD85j+ NK cells requires NK-DC contact and does not apparently depend on soluble factors
###end title 26
###begin p 27
###xml 122 126 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Oliva1">[24]</xref>
###xml 367 368 361 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 437 440 431 434 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bal</sub>
###xml 672 673 666 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 749 750 743 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 797 803 791 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g005">Fig. 5</xref>
###xml 985 986 979 980 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1017 1020 1011 1014 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bal</sub>
###xml 1090 1096 1084 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g005">Fig. 5</xref>
###xml 1177 1178 1171 1172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1375 1376 1366 1367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 54 57 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 276 281 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 329 332 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 432 435 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 492 497 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 498 502 <span type="species:ncbi:12721">GFP-</span>
###xml 776 781 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 844 849 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 897 900 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1012 1015 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1048 1053 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1151 1156 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1417 1420 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Activated NK cells secrete molecules that can control HIV infection, such as beta-chemokines and other inhibitory factors [24]. We then used transwell experiments to determine whether soluble inhibitory factors, such as beta-chemokines, secreted by NK cells in coculture with HIV-1-infected MDDC, were involved in the control of HIV infection, especially by the CD85j+ subset. Total NK cells and NK cell subsets were incubated with HIV-1Bal-infected DC or with uninfected DC (not shown), and HIV-1/GFP-infected DC were then added, as target cells, to transwell inserts that were placed in the NK-DC coculture-containing wells. A transient decrease in the percentage of GFP+ MDDC on day 8 was observed in the inserts placed on total NK cells or CD85j- NK cells cocultures with HIV-1-infected MDDC (Fig. 5). This weak and transient inhibition of HIV-1/GFP replication may be due to the secretion of HIV-inhibiting molecules by NK cells upon contact with infected MDDC. In contrast, CD85j+ NK cells cocultures with HIV-1Bal-infected DC did not affect HIV-1/GFP infection of DC in the inserts (Fig. 5). These results indicate that that the suppression of HIV-1 replication by CD85j+ NK cells in MDDC requires NK-MDDC contact but it is unlikely due to soluble factors. Accordingly, intracellular beta-chemokine staining did not show differences in the percentages of stained CD85j+ NK cells after 5 days of coculture with HIV infected MDDC compared to coculture with normal MDDC (results not shown).
###end p 27
###begin title 28
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 15 20 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Suppression of HIV-1 replication in DC by CD85j+ NK cells requires cell-to-cell contact and does not apparently depend on soluble factors.
###end title 28
###begin p 29
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 73 76 73 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bal</sub>
###xml 397 398 397 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 414 415 414 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 431 432 431 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 448 449 448 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 68 71 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 125 128 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 129 133 <span type="species:ncbi:12721">GFP-</span>
###xml 523 528 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 529 533 <span type="species:ncbi:12721">GFP-</span>
Total NK cells or the CD85j+ or CD85j- subsets were cocultured with HIV-1Bal-infected MDDC in the bottom of Transwell wells. HIV/GFP-infected MDDC were added to the inserts and GFP expression was monitored over time. The percentages of NK cells expressing GFP in the inserts placed on the different cell cultures are shown: MDDC cultures without NK cells (DC), with total NK cells (NK), with CD85j+ NK cells (CD85j+) and with CD85j- NK cells (CD85j-). Means+SE of 4 independent experiments. Significant differences between HIV-1/GFP-infected MDDC in transwell on MDDC/NK cocultures and on MDDC alone * p<0.05.
###end p 29
###begin title 30
###xml 51 52 51 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 19 22 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The suppression of HIV replication in MDDC by CD85j+ NK cells requires CD85j receptor interaction with MDDC surface ligands
###end title 30
###begin p 31
###xml 691 692 691 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 791 798 791 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g006">Fig. 6a</xref>
###xml 898 899 898 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1035 1042 1035 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g006">Fig. 6a</xref>
###xml 1269 1276 1269 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g006">Fig. 6a</xref>
###xml 1546 1547 1546 1547 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1874 1894 1874 1894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g004">Fig. 4b, A, D panels</xref>
###xml 2272 2291 2272 2291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g004">Fig. 4b, B,E panels</xref>
###xml 2436 2445 2436 2445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g004">Fig 4b, F</xref>
###xml 2514 2523 2514 2523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g006">Fig 6b, C</xref>
###xml 178 183 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 663 666 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1191 1194 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1294 1299 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1520 1523 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1819 1824 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1938 1943 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2251 2256 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2387 2392 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2635 2640 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The transwell experiments indicated that the suppression requires cell-to-cell contact. Furthermore, the down-regulation of CD85j expression observed on NK cells in contact with HIV-1-infected MDDC suggested engagement of the CD85j receptor. We therefore examined the role of the CD85j receptor interaction with its ligands on MDDC. Known CD85j ligands include classical and nonclassical HLA class I molecules. Thus, we used blocking antibodies specific for HLA-ABC, -E or -G to inhibit their interaction with CD85j. Furthermore, to block other potential interactions between CD85j and unknown ligands, we used a recombinant CD85j protein (rCD85j). Incubation of HIV-infected MDDC with CD85j+ NK cells diminished p24 production by about 90% compared to infected DC not exposed to NK cells. (Fig. 6a). Whereas antibodies blocking only one type of HLA (ABC, E or G) did not significantly modify CD85j+ NK cell-mediated viral suppression, the three anti-HLA Class I blocking Abs together only partially decrease p24 suppression (p<0.05) (Fig. 6a). Notably, incubation with rCD85j strongly reduced viral suppression (p<0.001). Viral suppression was further reduced by simultaneous incubation of HIV-infected MDDC with both the three anti-HLA class I antibodies and rCD85j (Fig. 6a). The removal of HIV-1 inhibition by rCD85j was not attributable to loss of NK cells by cytotoxicity, since NK cell number was comparable in NK-MDDC cocultures with or without rCD85j (data not shown). These results suggest that the control of HIV infection by the CD85j+ NK subset requires CD85j interaction with ligands expressed on infected MDDC, which may include, but are not limited to HLA Class I molecules. We then measured CD85j ligand expression on MDDC by flow cytometry. Approximately 90% of MDDC, either uninfected (top panel) or HIV-1-infected (bottom panel), were stained by rCD85j (Fig. 4b, A, D panels). In parallel, we incubated uninfected and HIV-1-infected MDDC with saturating concentrations of rCD85j or non-conjugated anti-HLA Class I mAbs and measured residual exposure of HLA Class I molecules and rCD85j ligands, respectively. After blockade with rCD85j, staining by the anti-HLA Class I-PE Ab was almost completely abolished in both uninfected and HIV-1-infected MDDC (Fig. 4b, B,E panels). In contrast, when HLA class I molecules were masked with anti-HLA Class I Abs, a fraction of HIV-1 infected MDDC was still stained by rCD85j (Fig 4b, F), whereas only a residual staining was detected on uninfected MDDC (Fig 6b, C). These results suggest that CD85j ligands distinct from HLA class I molecules are preferentially expressed on HIV-1-infected MDDC.
###end p 31
###begin title 32
###xml 118 123 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Involvement of NK CD85j receptor interaction with CD85j/ligands, including non-HLA class I ligands, in the control of HIV-1 replication in MDDC.
###end title 32
###begin p 33
###xml 31 34 31 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bal</sub>
###xml 59 60 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 521 525 521 525 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bal-</sub>
###xml 788 789 788 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 973 976 973 976 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bal</sub>
###xml 1672 1678 1668 1674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">italic</italic>
(a) MDDC were infected with HIVBal and incubated with CD85j+ NK cells after blocking CD85j receptor interactions with HLA class I molecules on the MDDC by treatment with Mabs to HLA class I ABC (HLA-ABC), E (HLA-E) or G (HLA-G) or by incubating MDDC with a recombinant CD85j protein (rCD85j). Blocking reagents were also added during coculture. MDDC infection was evaluated by measuring p24 in the supernatants 10 days later. The results are expressed as the percentage suppression of p24 (mean+SE) in comparison with HIVBal-infected MDDC not exposed to NK cells in 8 independent experiments. Significant differences in the levels of p24 suppression after incubation with the three anti-HLA class I Abs, with rCD85j or with rCD8j more the three anti-HLA class I Abs in comparison to CD85j+ NK cells cultured with infected DC without Abs are indicated by asterisks: * p<0.05, **p<0.001 (b) Flow cytometric analysis of rCD85j binding to uninfected MDDC (top panels) or to HIVBal-infected MDDC (bottom panels). MDDC staining with rCD85j as revealed by anti-hIgG-PE Abs (A and D). MDDC staining with a mix of anti-HLA Class I-PE mAbs after incubation with rCD85j (B and E), or with rCD85j and anti-hIgG-PE Abs after incubation with a mix of anti-HLA Class I MAbs. A representative experiment of three is shown. Without rCD85j blockade, nearly all MDDC were stained by anti-HLA-PE (not shown). The concentrations of anti-HLA class I Abs used in blocking experiments (10 microg/ml of each anti-HLA class I A,B,C, E and G) totally prevented the detection of HLA class I molecules on MDDC by using labelled anti-HLA class I Abs (not shown). Percentages of positive cells and MFI (italic) are shown. Range of positive rCD85j cells was between 8.2 and 21.9.
###end p 33
###begin title 34
Discussion
###end title 34
###begin p 35
###xml 160 168 160 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 351 352 351 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 468 469 468 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 646 647 646 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 123 126 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 265 270 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 390 395 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 489 494 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In this study, we examined changes in the NK cell repertoire and functions occurring in response to early interaction with HIV-infected DC, using an autologous in vitro NK/MDDC coculture system. We found that NK cell receptor expression is modulated in response to HIV-1 infection of MDDC, including strong CD85j down-regulation. Remarkably, the CD85j+ NK cell subset effectively inhibited HIV-1 replication in MDDC by affecting a post-entry step of viral cycle. CD85j+ NK cell-control of HIV-1 replication was apparently independent of NK cell cytotoxicity or release of soluble anti-viral factors, required NK-DC contact and might involve CD85j+ interaction with non HLA class I ligands.
###end p 35
###begin p 36
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-LopezBotet1">[25]</xref>
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-LopezBotet1">[25]</xref>
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-ValesGomez1">[26]</xref>
###xml 543 544 543 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 621 628 621 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g003">Fig. 3b</xref>
###xml 724 725 724 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 773 774 773 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 854 855 854 855 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 918 919 918 919 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1055 1061 1055 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g004">Fig. 4</xref>
###xml 1196 1197 1196 1197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1339 1346 1339 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g003">Fig. 3b</xref>
###xml 1393 1399 1393 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g005">Fig. 5</xref>
###xml 1401 1405 1401 1405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Oliva1">[24]</xref>
###xml 1425 1426 1425 1426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1583 1589 1583 1589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g005">Fig. 5</xref>
###xml 1684 1685 1684 1685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1780 1781 1780 1781 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1891 1892 1891 1892 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1960 1967 1960 1967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001975-g002">Fig. 2b</xref>
###xml 247 252 <span type="species:ncbi:9606">human</span>
###xml 253 256 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 336 341 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 600 605 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 698 703 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 797 802 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 949 954 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1090 1093 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1369 1372 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1485 1488 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1754 1759 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1865 1870 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
CD85j, also known as LIR-1/ILT2/LILRB1, is an inhibitory receptor expressed on NK cells and other hematopoietic cells [25]. The known ligands for CD85j are classical and nonclassical HLA Class I molecules [25] and a viral ligand, UL18, encoded by human CMV [26]. The down-regulation of the CD85j receptor on NK cells after contact with HIV-1-infected MDDC observed in this study suggests receptor engagement with ligands on the MDDC surface. Thus, it is possible that inhibitory signals through the CD85j receptor may explain the loss of CD85j+ NK cell cytotoxicity against MDDC after coculture with HIV-1-infected MDDC (Fig. 3b). Interestingly, despite the loss of their lytic activity induced by HIV-1-infected MDDC, CD85j+ NK cells were far more effective than the CD85j- subset in suppressing HIV-1 replication in infected MDDC. Indeed, whereas CD85j- NK cells induced partial and transient viral inhibition, CD85j+ NK cells potently suppressed HIV-1 replication when added early to infected MDDC as well as 5 days after coculture with infected MDDC (Fig. 4). The mechanisms underlying HIV inhibition by the two NK cell subsets appear different. The partial control of MDDC infection by CD85j- NK cells, observed in single-round infections and, transiently, in productive infections, may be due to both their preserved lytic capacity (Fig. 3b) and the secretion of HIV-inhibiting factors (Fig. 5) [24]. In contrast, CD85j+ NK cells exhibited low lytic activity and did not secrete HIV-inhibitory factors during coculture with infected MDDC, as assessed by transwell experiments (Fig. 5). Therefore, although we cannot formally rule out the secretion of inhibitory factors by CD85j+ NK cells at the immunological synapses with DC, it is unlikely that HIV-1 suppression by CD85j+ NK cells was mediated by either cytotoxicity or soluble factors. The inhibition of HIV-1 replication by CD85j+ NK cells was effective since the first cycle of viral replication (Fig. 2b), affecting either post-entry preintegration steps or viral transcription.
###end p 36
###begin p 37
###xml 104 105 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 764 765 764 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 70 75 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 235 238 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 330 333 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 697 702 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 957 960 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1138 1143 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1296 1299 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1315 1320 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1357 1362 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1377 1382 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1509 1512 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Taken together, our results support the hypothesis that inhibition of HIV-1 replication in MDDC by CD85j+ NK cells is directly or indirectly triggered by signals induced by interaction of the CD85j receptor on NK cells with ligands on HIV-infected MDDC. Indeed, blockade of NK CD85j interaction with MDDC surface molecules lifted HIV inhibition to various degrees. In particular, blockade of CD85j interactions with HLA Class I molecules only slightly lifted the inhibition, whereas a recombinant CD85j molecule almost totally abolished the inhibition of viral replication in MDDC. Inhibition of other NK receptors recognizing HLA class I molecules might also contribute to the partial removal of HIV-1 suppression by the anti-HLA Abs. Conversely, removal of CD85j+ NK cell-mediated viral inhibition by rCD85j points to the existence of a CD85j ligand other than HLA Class I A, B, C, E and G molecules, and suggests that NK cells use this ligand to inhibit HIV replication in MDDC. The results of competition experiments with anti-HLA class I Abs and rCD85j support this hypothesis. Indeed, a significant binding of CD85j was detected on HIV-1 infected MDDC after masking HLA class I molecules. It is tempting to speculate that the MDDC non-HLA class I ligand that mediates NK cell inhibition of HIV replication in HIV-1-infected MDDC might be modulated by HIV-1 or related to HIV-1 proteins. Further work is needed to identify the non-HLA class I ligand(s) recognized by the CD85j receptor on the surface of HIV-infected MDDC.
###end p 37
###begin p 38
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Mavilio2">[14]</xref>
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-OConnor1">[27]</xref>
###xml 391 395 391 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Mavilio2">[14]</xref>
###xml 397 401 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-OConnor1">[27]</xref>
###xml 445 446 445 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 523 524 523 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 579 587 579 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 603 607 603 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Alter4">[20]</xref>
###xml 655 656 655 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 107 112 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 122 130 <span type="species:ncbi:9606">patients</span>
###xml 232 237 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 464 469 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 485 490 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 561 566 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 683 688 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
An increased expression of CD85j on NK cells has been reported in both viremic and long term nonprogressor HIV-1-infected patients [14], [27]. While the significance of this observation is unclear, the role of the CD85j receptor in HIV-1 infection has only been analyzed and discussed with respect to its inhibitory activity on NK cytolytic activity (usually measured on a target cell line) [14], [27]. In this paper, we show evidence that CD85j+ NK cells control HIV-1 replication in HIV-1-infected MDDC. Recently, KIR3DS1+ NK cells have been shown to inhibit HIV-1 replication in vitro in CD4 T cells [20]. It will be interesting to assess whether CD85j+ NK cells can also control HIV-1 replication in CD4 T cells and macrophages.
###end p 38
###begin p 39
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 212 216 212 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Alter2">[12]</xref>
###xml 310 311 310 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 556 563 556 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ex vivo</italic>
###xml 51 56 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 114 119 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 284 289 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 529 532 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 712 715 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Should the interaction between CD85j+ NK cells and HIV-1-infected DC prove to contribute to host defences against HIV-1 infection, it is probable that it would intervene early, when NK cell activity is increased [12] and the virus has not yet disseminated. Indeed, the suppression of HIV-1 replication by CD85j+ NK cells in the first viral cycle, before viral spread in DC cultures, suggests that this mechanism may contribute to the early containment of the infection. Unfortunately, data on CD85j expression by NK during early HIV infection are lacking. Ex vivo studies of acutely infected individuals and/or simian models should provide new insights into the role of NK cells in early innate defences against HIV infection.
###end p 39
###begin title 40
Materials And Methods
###end title 40
###begin title 41
Generation of MDDC
###end title 41
###begin p 42
###xml 592 593 592 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 726 727 726 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 736 737 736 737 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1004 1005 1004 1005 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Peripheral blood mononuclear cells (PBMC) were prepared from blood of healthy donors by Ficoll-Paque density gradient centrifugation. PBMC were obtained through the French blood bank (Etablissement Francais du Sang) in the setting of EFS-Institut Pasteur Convention. A written agreement was obtained for each donor to use the cells for clinical research according to French laws. Our study was approved by IRB, external (Etablissement Francais du Sang Board) as required by French law and internal (Biomedical Research Committee Board, Institut Pasteur) as required by Pasteur Institute. CD14+ PBMC were isolated with anti-CD14 MicroBeads, MS+/RS+ columns and a MiniMACS separator. Monocyte-derived DC were generated from CD14+ PBMC (106/ml) by seeding in 6-well plates in DMEM medium plus 10% FCS; rhIL-4 and rhGM-CSF were added at final concentrations of 500 and 1000 U/ml, respectively, on days 0, 2 and 4. On day 5, floating immature DC (iDC) were transferred to new plates at a concentration of 3x105 cells/ml. Phenotype of iDC was verified by CD80, CD83, HLA DR and HLA Class I expression and the absence of CD14. Maturation capacity of iDC was assessed upon LPS stimulation.
###end p 42
###begin title 43
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 infection of MDDC
###end title 43
###begin p 44
###xml 32 34 32 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 56 59 56 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bal</sub>
###xml 81 82 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</sup>
###xml 170 173 170 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Ancuta1">[28]</xref>
###xml 297 298 297 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</sup>
###xml 299 300 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 357 361 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-PerezBercoff1">[29]</xref>
###xml 651 652 651 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 51 54 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 95 100 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 229 234 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 301 306 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
iDC were infected either with 10-1 m.o.i of the R5 HIV-1Bal strain or of NL.4/nef-/Bal env/GFP HIV-1, containing the green fluorescent protein (GFP) gene in the place of nef (a gift from P. Ancuta [28]), referred to hereafter as HIV-1/GFP. For single round infections, Bal Env pseudotyped NL-Luc-E-R+ HIV-1 particles were produced and titrated as described [29] and then used at 400 ng p24/ml. After 96 h, cells were lysed with a luciferase lysis buffer (Promega, Paris, France) and the luciferase activity was measured with a Luminometer (Glomax, Turener Biosystem, Promega, Paris, France). All infections were performed by spinoculation (1 h at 800 g followed by 1 h incubation at 37degreesC).
###end p 44
###begin title 45
Isolation of NK cells
###end title 45
###begin p 46
###xml 149 150 149 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 403 407 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-ScottAlgara2">[21]</xref>
###xml 409 413 409 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001975-Ravet1">[22]</xref>
###xml 709 710 707 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 260 264 <span type="species:ncbi:9913">calf</span>
###xml 544 549 <span type="species:ncbi:10090">mouse</span>
NK cells were negatively selected by using the NK cell isolation kit MicroBeads, MS+/RS+ columns and a MiniMACS separator. The percentage of CD3-CD56+ NK cells in the isolated population, evaluated by flow cytometry, was>95%. NK cells were frozen in 90% fetal calf serum, 10% DMSO, until cocultured with autologous MDDC. We have previously established that NK cell activity was not affected by freezing [21], [22], To purify CD85j NK cell subsets, NK cells were incubated with an antiCD85j MAb (Beckman Coulter, Paris, France) followed by anti-mouse IgG microbeads. The proportion of NK cells expressing the CD85j receptor before enrichment was 29+/-16%. Purified preparations contained more than 90% of CD85j+ cells.
###end p 46
###begin title 47
NK/MDDC coculture
###end title 47
###begin p 48
###xml 489 490 487 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 521 522 517 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 653 656 649 652 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bal</sub>
###xml 241 244 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 648 651 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 699 702 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 703 707 <span type="species:ncbi:12721">GFP-</span>
NK/MDDC were cocultured in DMEM+10% FCS in 24-well plates at a ratio of 1:5. An NK-DC ratio of 1:5 that induced optimal activation and proliferation of NK cells in preliminary studies was chosen for experiments. After 5 days of culture with HIV-infected or uninfected MDDC, NK cells were collected and analysed. Cell viability during cocultures was measured by propidium iodine (PI) staining: percentages of PI stained MDDC at day 14 of coculture were 25%+/-11 with total NK cells or CD85j- NK cells and 13+/-6 with CD85J+ NK cells. PI staining of NK cells was always below 5%. In Transwell experiments, NK cells were cocultured with uninfected or HIV-1Bal-infected MDDC in the bottom of the wells. HIV/GFP-infected MDDC were added to the inserts and GFP expression was recorded over time.
###end p 48
###begin title 49
Proliferation and phenotypic analysis
###end title 49
###begin p 50
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 49 50 49 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
NK cells (5x104) were incubated with MDDC (2.5x105) for 5 days in DMEM plus 10% FCS in 96-well round-bottom microtiter plates. NK were loaded with 5 microM CFSE before culture and proliferation was analyzed by measuring the decrease in fluorescence intensity, simultaneously with NK receptor expression. For the detection of NK cell receptors by flow cytometry, MAbs from Beckman Coulter and RD Systems were used (Paris, France).
###end p 50
###begin title 51
###xml 47 50 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Analysis of NK cell cytolytic activity against HIV-infected MDDC
###end title 51
###begin p 52
###xml 197 200 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 298 303 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 350 354 <span type="species:ncbi:11676?0.7906976744186046">HIV1</span>
This study was based on immunostaining of NK cells (CD3-CD8+/-CD16+CD56+) and detection of target MDDC cell lysis by caspase flow cytometry (CyToxiLux kit, Oncoimmunin Inc, USA). Specific lysis of HIV-infected MDDC populations was evaluated by combining caspase detection with MDDC infection by an HIV-1/GFP virus. Autologous MDDC were infected with HIV1/GFP seven days before the test, then surface-stained (following the manufacturer's instructions) and placed in contact with NK cells from 5-day MDDC cocultures for one hour in the presence of a fluorogenic caspase substrate. After incubation, lysis was analysed by flow cytometry gating on target cells (surface staining and GFP expression). Measures of NK cytolytic activity by caspase assay and the chromium release technique showed good correlation (r = 0.89)
###end p 52
###begin title 53
Blocking experiments
###end title 53
###begin p 54
Blocking experiments were performed with optimal concentrations of either anti-HLA class I antibodies or recombinant CD85j protein. MDDC were incubated with 10 microg/ml anti-HLA-class I mAb W6/32 (Serotec, Paris, France), or anti-HLA-class G mAb (Serotec, Paris, France), or anti-HLA-class E Mab (Serotec, Paris, France) or a mix of the three mAbs, or with a recombinant Fc-CD85j (rCD85j) fusion protein (RD System, Paris, France) at 20 microg/ml for 30 min at room temperature before adding NK cells. Antibodies or rCD85j were added to the cocultures every two days.
###end p 54
###begin title 55
Statistical analyses
###end title 55
###begin p 56
###xml 179 180 179 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
All experiments were done in independent triplicates or quadruplicates. Data were analyzed with nonparametric (Mann-Whitney test) and parametric tests (Student's two-sided paired t-test). The results are expressed as means+/-SE.
###end p 56
###begin p 57
We thank all the donors for their participation in this study. We thank Dr. S. Kottilil for comments on the manuscript.
###end p 57
###begin title 58
References
###end title 58
###begin article-title 59
###xml 54 60 <span type="species:ncbi:9606">humans</span>
NK cell activating receptors and tumor recognition in humans.
###end article-title 59
###begin article-title 60
###xml 55 60 <span type="species:ncbi:9606">human</span>
Activation, coactivation, and costimulation of resting human natural killer cells.
###end article-title 60
###begin article-title 61
Early liaisons between cells of the innate immune system in inflamed peripheral tissues.
###end article-title 61
###begin article-title 62
###xml 63 68 <span type="species:ncbi:9606">human</span>
Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease.
###end article-title 62
###begin article-title 63
Effector and regulatory events during natural killer-dendritic cell interactions.
###end article-title 63
###begin article-title 64
Multi-directional cross-regulation of NK cell function during innate immune responses.
###end article-title 64
###begin article-title 65
###xml 20 25 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
NK cell function in HIV-1 infection.
###end article-title 65
###begin article-title 66
###xml 32 37 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Natural killer cell function in HIV-1 infected patients.
###end article-title 66
###begin article-title 67
###xml 110 115 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection.
###end article-title 67
###begin article-title 68
###xml 41 44 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Natural killer (NK) cell activity during HIV infection: a decrease in NK activity is observed at the clonal level and is not restored after in vitro long-term culture of NK cells.
###end article-title 68
###begin article-title 69
###xml 46 51 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis.
###end article-title 69
###begin article-title 70
###xml 70 75 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Evolution of innate and adaptive effector cell functions during acute HIV-1 infection.
###end article-title 70
###begin article-title 71
###xml 86 91 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection.
###end article-title 71
###begin article-title 72
###xml 104 107 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.
###end article-title 72
###begin article-title 73
###xml 19 47 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function.
###end article-title 73
###begin article-title 74
###xml 106 109 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Expression of chemokine and inhibitory receptors on natural killer cells: effect of immune activation and HIV viremia.
###end article-title 74
###begin article-title 75
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates.
###end article-title 75
###begin article-title 76
###xml 12 15 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
NK cells in HIV infection: paradigm for protection or targets for ambush.
###end article-title 76
###begin article-title 77
###xml 57 62 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.
###end article-title 77
###begin article-title 78
###xml 56 61 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes.
###end article-title 78
###begin article-title 79
###xml 44 49 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users.
###end article-title 79
###begin article-title 80
###xml 95 98 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals.
###end article-title 80
###begin article-title 81
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV interactions with dendritic cells: has our focus been too narrow?
###end article-title 81
###begin article-title 82
###xml 26 54 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 56 59 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 136 141 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.
###end article-title 82
###begin article-title 83
Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection.
###end article-title 83
###begin article-title 84
###xml 89 110 <span type="species:ncbi:10359">human cytomegalovirus</span>
Genetic variability of the major histocompatibility complex class I homologue encoded by human cytomegalovirus leads to differential binding to the inhibitory receptor ILT2.
###end article-title 84
###begin article-title 85
###xml 51 54 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Natural Killer cells from long-term non-progressor HIV patients are characterized by altered phenotype and function.
###end article-title 85
###begin article-title 86
###xml 27 30 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
CD16+ monocytes exposed to HIV promote highly efficient viral replication upon differentiation into macrophages and interaction with T cells.
###end article-title 86
###begin article-title 87
###xml 41 76 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 100 105 <span type="species:ncbi:9606">human</span>
Fcgamma receptor-mediated suppression of human immunodeficiency virus type 1 replication in primary human macrophages.
###end article-title 87
###begin p 88
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 88
###begin p 89
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by grants from Sidaction and the National Agency for AIDS Research (ANRS), France.
###end p 89

